![portolapharm.com](http://dlcache.com/sthumb/b01/portolapharm.com.gif) |
Portola Pharmaceuticals, Inc. Discovering and developing novel therapeutics.
Portola Pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases Portolas two most advanced programs are in Phase II clinical trials: 1) betrixaban, an oral, once-daily Factor Xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (SPAF) and for prevention of venous thromboembolism (VTE) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. ADP receptor antagonist initially being developed for patients with acute coronary syndrome (ACS).
Portolapharm.com ~
Site Info
Whois
Trace Route
RBL Check
Similar Sites:
portolapharm.net
- portolapharm.org
- elinogrel.net
|
|
|
|